Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Clinical trial NCT06999980 · RECRUITING

Trial details

NCT number: NCT06999980
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma Mucosal Melanoma

Start date: 2026-02-09
Primary completion: 2028-03-01
Enrollment: 494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.